Pulse Biosciences
PLSE
43 hedge funds and large institutions have $25.3M invested in Pulse Biosciences in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 8 closing their positions.
410% more call options, than puts
Call options by funds: $948K | Put options by funds: $186K
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
23% more capital invested
Capital invested by funds: $20.5M → $25.3M (+$4.77M)
0.9% more ownership
Funds ownership: 8.99% → 9.89% (+0.9%)
9% less funds holding
Funds holding: 47 → 43 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.9M |
| 2 |
SCP
Silverleafe Capital Partners
Germantown,
Tennessee
|
+$559K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$446K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$241K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$235K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$487K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$431K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$291K |
| 4 |
VF
Virtu Financial
New York
|
-$157K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$45K |
PLSE Hedge Fund Activity: Q2 2018 in Review
43 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2018, worth a combined $25.3M — up 23% from $20.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of PLSE and 4 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 17 added.
The largest buyer was BlackRock, adding an estimated $1.9M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $487K sold.
- 43 institutional investors held Pulse Biosciences (PLSE) as of Q2 2018, down from 47 in Q1 2018.
- Funds reported $25.3M of Pulse Biosciences stock for Q2 2018, up 23% quarter-over-quarter.
- 4 funds opened new Pulse Biosciences positions in Q2 2018 and 8 closed out, a net change of -4 holders.
- The largest Pulse Biosciences buyer in Q2 2018 was BlackRock, an estimated $1.9M added.
- The largest Pulse Biosciences seller in Q2 2018 was Susquehanna International Group, an estimated $487K sold.
Based on aggregated 13F filings for Q2 2018.